论文部分内容阅读
结核病只有通过培养、分离出结核菌才能明确诊断。对未接种过卡介苗的病人,结核病纯蛋白衍化物(PPD)皮试,也可为结核感染提供依据。本指南提出了如何对那些治疗和预防(辅助性预防)结核感染的新药进行评估。临床试验中选择的病人必须符合临床和/或微生物学的诊断标准。治疗方案为多种药物的联合,并介绍了一种随机、有效对照、可比较的临床试验。如果能够保证从随访的病人中获取到供培养用的所需标本,由此对微生物学检测结果做出的评估是最具权威性的。预防仅需一种药
Only through the cultivation of tuberculosis, tuberculosis can be isolated to confirm the diagnosis. For patients who have not been vaccinated with BCG, skin test of pure protein derivative of tuberculosis (PPD) can also provide basis for tuberculosis infection. This guideline assesses how to treat new drugs for the treatment and prophylaxis (adjuvant prevention) of tuberculosis. Patients selected for clinical trials must meet clinical and / or microbiological diagnostic criteria. The treatment regimen is a combination of multiple drugs and introduces a randomized, controlled, and comparable clinical trial. Assessing the results of microbiological tests is the most authoritative if it is guaranteed that the desired specimen for culture will be available from follow-up patients. Prevention is only one medicine